🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of Kidney Function by Electrical Impedance Tomography (EIT)

Recruitingn/aAges 18 Years - 90 YearsAllThe University of Hong Kong
NCT06898294 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The product under investigation is named Gense EIT-kidney device. This kidney device is a portable and non-invasive imaging modality capable of capturing the cross-sectional bioelectrical impedance distribution of the kidney at multiple current injection frequencies using electrical impedance tomography (EIT). Currently, the kidney device employs a band consisting of 16 equally distributed electrodes around the abdomen. The electrode band is connected to a control unit that switches the electrode stimulation and measurement pairs, then sends the collected measurement to a computational unit for image reconstruction. The images are then post-processed to extract functional kidney images for diagnosis. This kidney device can connect to an external screen, allowing the functional images to be produced and visualized.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: \- clinically diagnosed with CKD at different stages (stage 1-5) of the disease based on GFR measurement results Age: 18-90. Gender: Male/ Female Exclusion Criteria: * ● Subjects with known kidney disease or abnormalities (for the control group). * Subjects who had any kind of kidney surgery or kidney transplantation. * Subjects with damaged skin on the abdomen. * Subjects with implanted electronic devices. * Subjects with spinal diseases/discomfort * Subjects who had any recent abdominal surgery * Pregnant women. * Obese subjects (BMI\>35). * Subjects with uncontrollable involuntary body movements such as degenerative disorders (e.g., Alzheimer's and Parkinson's disease); Seizure disorders (e.g., epilepsy, stroke, neuroleptic drugs); Neurological disorders (e.g., tardive dyskinesia and cerebral palsy, tremors, myoclonus, tics, athetosis, etc.)
💊

What it tests

  • EIT kidney function assessment
📍

Where

1 site
Queen Mary Hospital, Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy